Nab-paclitaxel is effective against intrahepatic cholangiocarcinoma via disruption of desmoplastic stroma

Intrahepatic cholangiocarcinoma (IH-CCA) is the second predominant hepatic malignancy worldwide. However, effective treatment strategies for IH-CCA have not yet been developed. Nab-paclitaxel may be an effective drug against IH-CCA, a type of desmoid-like tumor, and its antitumor effects may be attr...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncol Lett
Auteurs principaux: Chang, Peter Mu-Hsin, Cheng, Chi-Tung, Wu, Ren-Chin, Chung, Yi-Hsiu, Chiang, Kun-Chun, Yeh, Ta-Sen, Liu, Chun-Yu, Chen, Ming-Han, Chen, Ming-Huang, Yeh, Chun-Nan
Format: Artigo
Langue:Inglês
Publié: D.A. Spandidos 2018
Sujets:
Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6019977/
https://ncbi.nlm.nih.gov/pubmed/29963132
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2018.8690
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires